By inhibiting the MR and subsequently downregulating the expression of Gnαi2, finerenone treatment significantly suppressed the over-activation of the complement C5a-C5aR1 axis and associated chemotaxis damages, thereby alleviating kidney damages in DN. The gene discussed is C5AR1; the disease is liver dysplastic nodule.